cAMP Signaling
| Category | Mechanisms |
|---|---|
| Also known as | cyclic AMP pathway, PKA signaling |
| Last updated | 2026-04-14 |
| Reading time | 3 min read |
| Tags | mechanismsignalingsecond-messenger |
Overview
Cyclic AMP (cAMP) was the first second messenger ever described — by Earl Sutherland in his studies of glycogenolysis — and remains one of the most important signaling molecules in biology. It is generated from ATP by adenylyl cyclase in response to activation of Gs-coupled GPCRs, and it conveys hormonal and neurotransmitter signals into cells to regulate metabolism, secretion, contractility, memory, and gene expression.
The classical cAMP effector is protein kinase A (PKA), a tetrameric enzyme whose catalytic subunits are released from regulatory subunits upon cAMP binding. PKA phosphorylates hundreds of substrates, modulating glycogen phosphorylase, CREB transcription factor, ion channels, and structural proteins. A second major effector, Epac, directly activates the small GTPase Rap1 and contributes to many physiological processes including insulin secretion and cardiac function.
cAMP signaling is heavily compartmentalized. A-kinase anchoring proteins (AKAPs) tether PKA near specific substrates, while phosphodiesterases (PDEs) shape local concentration gradients by degrading cAMP at defined microdomains. This compartmentalization allows a single messenger to produce many distinct cellular responses depending on which local pool is activated.
Mechanism / Process
-
Receptor activation. A Gs-coupled GPCR — beta-adrenergic, glucagon, GLP-1, dopamine D1, PTH, many others — binds ligand.
-
G protein cycling. Galpha-s dissociates from Gbeta-gamma and activates transmembrane adenylyl cyclases (AC1-AC9).
-
cAMP generation. Adenylyl cyclase converts ATP to cAMP. Concentrations rise locally within seconds.
-
PKA activation. cAMP binds PKA regulatory subunits, releasing catalytic subunits that phosphorylate serine and threonine substrates.
-
Epac activation. cAMP also binds Epac (exchange protein activated by cAMP), which activates Rap1 for small GTPase signaling.
-
Transcriptional consequences. PKA phosphorylates CREB at Ser133, recruiting coactivators CBP and p300 and driving transcription of CREB target genes.
-
Termination. Phosphodiesterases (PDE1-11) hydrolyze cAMP to 5'-AMP. Gi-coupled receptors oppose cAMP generation by inhibiting adenylyl cyclase.
-
Localization. AKAPs anchor PKA to specific organelles, receptors, or ion channels, creating signaling microdomains.
Key Players / Molecular Components
- Adenylyl cyclases (AC1-AC9). Isoform-specific regulation by Galpha-s, Galpha-i, calcium, and protein kinases.
- PKA. Type I and II holoenzymes with different regulatory subunits and AKAP preferences.
- Epac1, Epac2. cAMP-dependent Rap GEFs.
- Phosphodiesterases (PDE1-11). Hydrolyze cAMP and/or cGMP; subject to compartment-specific regulation.
- AKAPs. Tether PKA to substrates, creating local signaling nodes.
- CREB and ATF family transcription factors. Transcriptional endpoint of many cAMP signals.
Clinical Relevance / Therapeutic Targeting
cAMP signaling is a major therapeutic axis. Beta-agonists for asthma (albuterol) and heart failure (dobutamine) activate the pathway; beta-blockers dampen it. Glucagon and GLP-1 agonists raise cAMP in hepatocytes and beta cells, respectively. PDE inhibitors include caffeine (nonspecific), theophylline (asthma), milrinone (acute heart failure, PDE3), sildenafil and tadalafil (PDE5 for vasodilation), rolipram (PDE4, depression/inflammation), and apremilast (PDE4 for psoriasis). Constitutive activation of cAMP signaling drives tumor formation in McCune-Albright syndrome (Galpha-s mutation) and certain pituitary and adrenal tumors.
Peptides That Target This Pathway
- GLP-1 analogs — Gs-coupled, raise beta-cell cAMP to stimulate glucose-dependent insulin secretion.
- Glucagon — raises hepatic cAMP to drive glycogenolysis and gluconeogenesis.
- Parathyroid hormone — cAMP signaling in bone and kidney.
- Vasopressin — V2 receptor raises cAMP in renal collecting duct.
- Adrenocorticotropic hormone (ACTH) — cAMP-dependent steroidogenesis in adrenal cortex.
- Secretin — pancreatic and duodenal cAMP signaling.
Related Topics
Related entries
- cGMP Signaling— The signaling pathway driven by cyclic GMP, generated by guanylyl cyclases in response to nitric oxide and natriuretic peptides, regulating vascular tone, vision, and secretion.
- GPCR Signaling Basics— Introduction to how G protein-coupled receptors detect extracellular signals and convert them into intracellular responses through heterotrimeric G proteins.
- Phosphorylation Signaling— The reversible attachment of phosphate groups to proteins, a dominant mechanism for rapid, dynamic regulation of protein function in cells.
- Second Messenger Systems— Small intracellular molecules that relay and amplify signals from receptors to downstream effectors, including cAMP, cGMP, IP3, DAG, and calcium.